Virtual Program

Thank you for your interest in the AMP 2020 Annual Meeting & Expo!

The AMP 2020 Program Committee has been working hard to plan a comprehensive program, which we hope will encourage dialogue and foster discussion amongst attendees. There will be additional On Demand sessions that will be listed and available for attendees to view at their leisure starting on November 16th and for several weeks after. All sessions will be available On Demand after the scheduled sessions air. The Expo Hall will be open for the duration of the event (and after), but opportunities to interact with representatives from the companies  LIVE will be limited to the times on the schedule. Please note: all times are Eastern Standard Time (EST).

 

Preliminary Program:

Be sure to check back for updated Program information often!

Quick Links

Monday

Tuesday

Wednesday

Thursday

Friday

Sunday, November 15, 2020

10:30am - 4:40pm

2020 Get AMPed! Updates and Case Studies in Molecular Pathology

(Separate Registration)

Monday, November 16, 2020

10:30am - 11:15am

Interactive Expo Hall

11:15am - 11:30pm

Opening Remarks

11:30pm - 1:00pm

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture 

Plasma DNA Based Molecular Diagnostics - From Dream to Reality

Dennis Lo, FRS, The Chinese University of Hong Kong, Hong Kong, China

1:00pm - 2:00pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

Molecular Methods for Discovery of Novel Pathogens

The Use of Molecular Tests in the Discovery and Characterization of Emerging Fungal Pathogens

Ilan Schwartz, MD, PhD, University of Alberta, Alberta, Canada

Molecular Methods for Discovery of Novel Pathogens

Lea Starita

Transitioning to hg38

GRCh38/hg38 and Transitioning to hg38

Justin Zook, PhD, National Inst of Standards & Tech, Gaithersburg, MD, USA

Look before you leap: How to systematically move clinical diagnostic testing from hg19 to hg38

Sabah Kadri, PhD, Lurie Children's Hospital of Chicago, Chicago, IL, USA

Integrative Analysis of the Tumor Microenvironment

Thomas Gajewski, MD, PhD, The University of Chicago, Chicago, IL, USA

Immune Cell Characterization via Multiplexed Digital Imaging

Scott Rodig, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA

Targeted Therapies for Constitutional  Genetic Disorders

Molecular Therapies for Cystic Fibrosis

Garry Cutting, MD, Johns Hopkins University, Baltimore, MD, USA

Case Studies in Hematopathology - On Demand

2:00pm - 3:00pm

Interactive Expo Hall with Demos and Drawings

3:00pm - 4:00pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

Implementation of Molecular Infectious Diagnostics Test at the Point-of- Care

Triumphs and Challenges Surrounding Implementation of Point-of-care Molecular Assays Outside of the Microbiology Laboratory

Omai Garner, PhD, UCLA, Los Angeles, CA, USA

Implementation of Molecular Infectious Diagnostics Test at the Point-of- Care

Raquel M. Martinez

Laboratory Assurance Compliance Solutions

Justin Hammerling, MBA, Kapios Health, Toledo, OH, USA

Guidance for Reevaluation and Reanalysis of Genomic Test Results

Josh Deignan, PhD, University of California, Los Angeles, CA, USA

Case Studies in Solid Tumors - On Demand

Epigenetics in Malignant Hematology - On Demand

Maria Figueroa, MD, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA

4:00pm - 5:00pm

Corporate Workshops

5:00pm - 5:45pm

Networking Events

Tuesday, November 17, 2020

11:00am - 11:45am

Interactive Expo Hall

11:45am - 12:00pm

Opening Remarks

12:00pm - 1:00pm

PLENARY SESSION

Single Cell Insights into Myeloid Neoplasia

Clonal Heterogeneity and Evolution of Myeloid Neoplasia with Single-Cell Genomics

Koichi Takahashi, MD, PhD, UT MD Anderson Cancer Center, Houston, TX, USA 

1:00pm - 2:00pm

Posters and Platforms

Platform Presentations of Selected Genetics Abstracts - On Demand
Platform Presentations of Selected Hematopathology Abstracts - On Demand
Platform Presentations of Selected Infectious Diseases Abstracts - On Demand

2:00pm - 3:00pm

Interactive Expo Hall with Demos and Drawings

3:00pm - 4:00pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

Tissue Stewardship: Maximizing the Information That Can Be Provided by Small Specimens

Best Practices for Tissue Allocation

Sinchita Roy Chowdhuri, MD, PhD, The University of Texas MD Anderson, Houston, TX, USA

Optimal Assay Design for Small Specimens

Christopher Gilbert, DO, MS, Swedish Cancer Institute, Seattle, WA, USA

Practical Approaches to Diagnostic Stewardship of Advanced Molecular Tests

Panel Discussion

Daniel DiekemaUniversity of Iowa, Iowa City, IA, USA

Neil Anderson, MD, Washington University in St. Louis, St. Louis, MO, USA

Amanda Harrington, PhD, D(ABMM), Loyola University Medical Center, Maywood, IL, USA

D. Jane Hata, PhD, Mayo Clinic Florida, Jacksonville, FL, USA

Single-cell Sequencing/Slide-Seq: A Scalable Method for Spatially Resolved Gene Expression Studies Using Single-cell RNA Sequencing

Cell Atlases as Roadmaps to Understand and Treat Disease

Orit Rozenblatt-Rosen, PhD, Broad Institute, Cambridge, MA, USA

Moving Towards Clinical-grade HGVS Nomenclature - On Demand

Case Studies in Genetics - On Demand

3:00pm - 6:00pm

SHORT COURSE - On Demand

Practical Guidelines on Validating Bioinformatics Pipelines 

4:00pm - 5:30pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

Variant Review and Classification Workshop

Laura Tafe, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

Somak Roy, MD, Cincinnati Children's Hospital Medical Center, Mason, OH, USA

Mark Routbort, MD, PhD, M. D. Anderson Cancer Center, Houston, TX, USA

High-Throughput Functional and Genomic Approaches for Understanding Germline and Somatic Variants

High-throughput Functional and Genomic Approaches

COVID-19 Molecular Testing: Experiences from the Field

Panel Discussion

Teresa Karre, MD, Nebraska Methodist Hospital and Children's Hospital and Medical Center, Omaha, NE, USA

Anthony Tran, DrPH, MPH, D(ABMM), District of Columbia Department of Forensic Sciences, Bethesda, MD, USA

Beth Marlowe, PhD, D(ABMM), Quest Diagnsotics, San Juan Capistrano, CA, USA

Michael Bachman, MD, PhD, University of Michigan/Michigan Medicine, Ann Arbor, MI, USA

Laboratory Economics During a Public Health Emergency: Lessons Learned (and still learning) from the COVID-19 Pandemic 

(Sponsored by the AMP Economic Affairs Committee)

5:30pm - 6:15pm

Networking Events

Wednesday, November 18, 2020

10:15am - 11:00am

Networking Event

11:00am - 11:45am

Interactive Expo Hall

11:45am - 12:00pm

Opening Remarks

12:00pm - 1:00pm

PLENARY SESSION

Coronavirus Pandemic Updates

Carlos Del Rio, MD, Emory School of Medicine, Atlanta, GA, USA

1:00pm - 2:30pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

Distributed Laboratories and Third Party Interpretation Services

Panel Discussion

Gail Javitt, Hyman, Phelps & McNamara, P.C., Washington, DC, USA

Matthew Lebo, PhD, Lab for Molecular Medicine, Mass General Brigham Personalized Medicine

Rakesh Nagarajan, PhD, MD, PierianDx

Point-Counter Point: Clinical Metagenomics Is Worth the Juice

Steve Miller, MD, PhD, University of California, San Francisco, CA, USA

William Muller, MD, PhD, Lurie Children's Hospital of Chicago; Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Stephanie Mitchell, PhD, D(ABMM), University of Pittsburgh, Pittsburgh, PA, USA

Debra Palazzi, MD, MEd, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA

Early Detection and Characterization of Cancer Using cfDNA and Distinction from Clonal Hematopoiesis

Pedram Razavi, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Bridging the Gap: Molecular Tumor Boards, Clinical Trials Matching, and the Pathologist-oncologist Interface

Precision Oncology through a Molecular Tumor Board: Hype or Reality?

Marios Giannakis, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

Cancer Clinical Decision Making Tools in the Era of Precision Medicine & Big Data

Mia Levy, MD, PhD, Rush University Medical Center, Chicago, IL, USA

2:30pm - 3:30pm

Interactive Expo Hall with Demos and Drawings

3:30pm - 4:30pm

Corporate Workshops

4:30pm - 5:30pm

Corporate Workshops

5:30pm - 6:15pm

Business Meeting

Thursday, November 19, 2020

11:00am - 11:45am

Interactive Expo Hall

11:45am - 12:00pm

Opening Remarks

12:00pm - 1:00pm

PLENARY SESSION

Machine Learning in Health Care

Machine Learning in Genomic Medicine

Stephen Kingsmore, MD, DSc, FRCPath, Rady Children's Institute for Genomic Medicine, San Diego, CA, USA

1:00pm - 2:00pm

Posters and Platforms

Platform Presentations of Selected Informatics Abstracts On Demand
Platform Presentations of Selected Solid Tumors Abstracts On Demand
Platform Presentations of Selected Technical Topics Abstracts On Demand

2:00pm - 3:00pm

Interactive Expo Hall with Demos and Drawings

3:00pm - 4:00pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

True or False: Interpretation Challenges of Blood Culture Identification Panels 

Pitfalls in Interpretation of Blood Culture Molecular ID Panels

Richard Davis, PhD, D(ABMM), MLS(ASCP)CM, Providence Sacred Heart Medical Center, Spokane, WA, USA

True or False: Interpretation Challenges of Blood Culture Identification Panels 

Susan Butler-Wu, LA County and USC Medical Center, Los Angeles, CA, USA

Addressing the Clinical Laboratory Workforce Shortage - Automation and Robotics

Addressing the Clinical Laboratory Workforce Shortage - Automation and Robotics

Jose Manuel Collados, ABB, Houston, TX, USA

Practical Guidelines on Validating Bioinformatics Pipelines Q&A

4:00pm - 5:30pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

What Do All These Mutations Mean?

How Do I Manage a Patient with CH?

Kelly Bolton, MD, PhD, Memorial Sloan Kettering Cancer Center, New York NY, USA

How Can I Use Mutation Data to Diagnose MDS in a Patient with Cytopenia and No Morphologic Dysplasia?

Amy Dezern, MD, MHS, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Genomics in Children: Coming of Age

The Current State of the Field in Pediatric Cancer Genomics

Sharon Plon, MD, PhD, Baylor College of Medicine, Houston, TX, USA

Utility of WGS in Molecular Analysis Pediatric Cancers Discussing the Pro’s and Con’s Within the Question of Clinical Utility

Jinghui Zhang, PhD, St. Jude Children's Research Hospital, Memphis, TN, USA

Enhanced Molecular Diagnosis Through Structural Variant Detection 

Application of New Methods of Structural Variant Detection in the Clinical Laboratory

Madhuri Hegde, PerkinElmer Genomics, Duluth, GA, USA

Mate Pair Sequencing as a Tool to Increase Diagnostic Yield for Constitutional Genetic Disorders

Nicole Hoppman, PhD, Mayo Clinic, Rochester, MN, USA

The Roadmap to Recognition of Molecular Professionals as Qualified Healthcare Professionals

(Sponsored by the AMP Professional Relations Committee)

Strain Typing in Clinical and Public Health Laboratory: Migration to Whole Genome Sequencing for Epidemiology Purposes - On Demand

Transitioning from Conventional Typing to Whole Genome Sequencing (WGS) for Public Health Epidemiology

William Glover, PhD, State Laboratory of Public Health, Raleigh, NC, USA

Strain Typing in Clinical and Public Health Laboratory: Migration to Whole Genome Sequencing for Epidemiology Purposes

Sanchita Das, MD, D(ABMM), NIH, Bethesda, MD, USA

5:30pm - 6:30pm

Innovation Spotlights

Friday, November 20, 2020

11:00am - 11:45am

Interactive Expo Hall

11:45am - 12:00pm

Opening Remarks

12:00pm - 1:00pm

PLENARY SESSION

DepMap: The Cancer Dependency Map Project

William Hahn, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

1:00pm - 2:30pm

CONCURRENT BREAKOUT SESSIONS with live Q&A discussions

Genomically-informed Lymphoma Classification

Molecular Updates in Classification of B-cell Lymphomas

Sandeep Dave, MD, Duke University, Durham, NC, USA

Molecular Updates in Classification of T-cell Lymphomas

Javeed Iqbal, MS, PhD, University of Nebraska Medical Center, Omaha, NE, USA

Whole Genome Sequencing for Antimicrobial Resistance Testing

Detection of Resistance-associated Mutations in Cytomegalovirus Through the Use of Next-generation Sequencing

Matthew Binnicker, PhD, Mayo Clinic, Rochester, MN, USA

Clinical Whole-genome Sequencing and Drug Resistance Reporting for Mycobacterium tuberculosis in New York: a 5 year summary

Kimberlee Musser, PhD, Wadsworth Center, Loudonville, NY, USA

Emerging Testing Paradigms and Insights

Experience from Proactive Whole Genome Sequencing in 400 Newborn Children

Steven Bleyl, MD, PhD, Genome Medical Services, San Francisco, CA, USA

Genetic Testing as an Employee Benefit

Scott Topper, PhD, Color, Burlingame, CA, USA

Translational Research Approaches to Large-scale Population Genomics

James Lu, PhD, Helix, San Mateo, CA, USA

Tumor Evolution and Therapeutic Resistance

In-silico Modeling of Tumor Evolution

Noam Auslander, PhD, National institute of Biotechnology Information, NIH, Bethesda, MD, USA

Molecular Archeology of Cancer

Peter Van Loo, PhD, The Francis Crick Institute, London, England, United Kingdom

Next Generation Data: Integration and Dissemination of Molecular Pathology Data - On Demand

Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Modern Application Deployment Strategies for NGS testing and Integration with Molecular Pathology Data

Cihan Kaya, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

2:30pm - 3:30pm

Interactive Expo Hall with Demos and Drawings

3:30pm - 4:30pm

PLENARY SESSION

Gene Therapy for Retinal Disorders

Elias I. Traboulsi, MD, M.Ed., Cleveland Clinic, Cleveland, OH, USA

 

4:30pm - 4:45pm

Closing Remarks